PCK — PainChek Income Statement
0.000.00%
Last trade - 00:00- AU$16.30m
- AU$14.56m
- AU$3.77m
Annual income statement for PainChek, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.994 | 1.96 | 2.67 | 3.36 | 3.77 |
| Cost of Revenue | |||||
| Gross Profit | -0.243 | 0.719 | 0.727 | 0.998 | 2.66 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.71 | 9.53 | 11 | 11 | 12.5 |
| Operating Profit | -5.72 | -7.57 | -8.31 | -7.67 | -8.74 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -5.72 | -7.57 | -8.31 | -7.67 | -8.94 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.72 | -7.57 | -8.31 | -7.67 | -8.94 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.72 | -7.57 | -8.31 | -7.67 | -8.94 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.72 | -7.57 | -8.31 | -7.67 | -8.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.049 | -0.058 | -0.056 | -0.044 | -0.043 |